Isabella Baldissarro
Genoa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Therapeutic drug monitoring in Crohn's disease patients treated with anti-TNF: a comparison of two techniques.
Journal: European journal of gastroenterology & hepatology
Published: August 02, 2021
Hepatic Elastometry and Glissonian Line in the Assessment of Liver Fibrosis.
Journal: Ultrasound in medicine & biology
Published: July 21, 2020
High anti-TNF alfa drugs trough levels are not associated with the occurrence of adverse events in patients with inflammatory bowel disease.
Journal: Scandinavian journal of gastroenterology
Published: September 26, 2019
Reduction in TIMP-2 serum levels predicts remission of inflammatory bowel diseases.
Journal: European journal of clinical investigation
Published: November 28, 2017
Cost per care of the first year of direct antiviral agents in the Liguria Region: a multicenter analysis.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: June 06, 2017
Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn's disease.
Journal: Scandinavian journal of gastroenterology
Published: May 22, 2016
Comparison of Two Different Techniques to Assess Adalimumab Trough Levels in Patients with Crohn's Disease.
Journal: Journal of gastrointestinal and liver diseases : JGLD
Published: December 24, 2015
Low serum trough levels are associated with post-surgical recurrence in Crohn's disease patients undergoing prophylaxis with adalimumab.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: June 24, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026